Skip to main content
. Author manuscript; available in PMC: 2014 Apr 15.
Published in final edited form as: Clin Cancer Res. 2013 Feb 26;19(8):2257–2264. doi: 10.1158/1078-0432.CCR-12-3476

Table 2.

Adverse events of grade 2 or greater possibly or probably attributable to selumetininb.

No. of patients
Toxicity Grade 2 Grade 3 Grade 4
Acneiform rash 3 2
↑ AST 2
↑ ALT 2 1
↑ Alk phosphatase 2 1
Anemia 2
↑ glucose 2
Fatigue 2
Diarrhea 2
↓ lymphocyte count 3
Edema 2
↓ albumin 1
↑ bilirubin 2 1
Dyspnea 1
↓ phosphate 1
LV dysfunction 2
RV dysfunction 1
Vomiting 1
Valvular heart disease 1
Chest wall pain 1
Heart failure 1
↓ magnesium 1
Pleural effusion 1